Ingersoll Rand Inc. ((IR)) has held its Q1 earnings call. Read on for the main highlights of the call.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Ingersoll Rand Inc. struck a cautiously upbeat tone on its latest earnings call, as solid revenue and EPS growth and standout performance in its PST segment offset visible pressure in its industrial technologies business. Management framed tariff and cost headwinds, as well as regional order delays, as transitory, leaning on strong cash generation, liquidity and M&A capacity to support confidence in the full‑year outlook.
Top-Line and EPS Growth Signal Solid Start
Total revenue grew 8% year over year in Q1 2026, while adjusted EPS rose 7% to $0.77, marking a steady start against expectations. Management emphasized that this performance reflects continued execution despite mixed end‑market conditions and rising cost and tariff pressures.
PST Segment Delivers Double-Digit Profit Growth
In the PST segment, orders climbed 6% with a book‑to‑bill of 1.04 times, supporting future revenue visibility. Organic revenue rose 4% and adjusted EBITDA surged 15% to $122 million, driving roughly 120 basis points of margin expansion and underscoring PST as the company’s profit engine.
Healthy Orders, Backlog and Book-to-Bill Support H2
Enterprise‑wide orders increased 5% with a company book‑to‑bill of 1.07 times, including 1.08 times in ITS, keeping backlog at supportive levels. Management pointed to backlog strength stretching into 2025 as a key reason for expecting stronger growth in the second half of 2026.
Strong Free Cash Flow and Balance Sheet Flexibility
Free cash flow of $163 million in Q1 tracked in line with internal plans, reinforcing the company’s cash‑generation credentials. With nearly $4 billion of liquidity, leverage well under two times and a targeted 95% free cash flow conversion for 2026, Ingersoll Rand highlighted ample financial capacity for growth and capital returns.
M&A Pipeline Positioned to Drive Inorganic Growth
Management detailed an active M&A funnel with over 200 potential targets and 10 signed letters of intent, about 90% of which are internally sourced. The recently signed Fox s.r.l. deal and broader pipeline are expected to deliver 400 to 500 basis points of annualized inorganic revenue in 2026, adding roughly 4% to 5% to growth.
Life Sciences and Strategic Wins Bolster Growth Narrative
Life Sciences orders grew at a double‑digit pace in Q1, supported by integration wins such as the ILC Dover collaboration and a large carbon capture vacuum and blower project. Management highlighted improving visibility and a healthy opportunity funnel in Life Sciences and short‑cycle businesses, positioning these areas as structural growth drivers.
ITS Margin Headwinds Weigh on Near-Term Profitability
In contrast, ITS margins remained under pressure, with adjusted EBITDA margin declining to 26.7% and marking a fifth straight quarter of year‑over‑year compression. The company cited volume deleverage, tariff impacts and stepped‑up commercial investments as the main drivers, while reiterating plans for back‑half margin recovery.
Middle East Order Delays Seen as Transitory
Roughly $40 million of long‑cycle orders tied to the Middle East conflict were delayed in the quarter, weighing on ITS orders. Management noted that about one‑third of these orders were recovered in April and expressed confidence that the balance should be realized over 2026 as conditions normalize.
Mixed Organic Orders Highlight ITS Weakness
Organic orders in ITS declined about 3% in Q1, though results would have been roughly flat excluding the Middle East delays. Certain product categories, including power tools, lifting and some compressor lines, were down versus last year, reflecting uneven demand patterns across end markets.
Tariffs and Costs Create Margin Drag, Recovery Back-End Loaded
Recent tariff changes, including Section 232 shifts, and direct material cost dynamics have pressured margins, particularly in ITS. Management expects pricing actions and mitigation efforts to offset these headwinds over 2026 on a full‑year basis, but acknowledged near‑term dilution and a back‑loaded recovery profile.
Near-Term Margin Trough Before Expected Improvement
Looking specifically at the next quarter, management guided to Q2 margins being down 50 to 100 basis points year over year, largely due to ITS. They described Q2 as a margin trough, with sequential improvement and expansion anticipated in the second half as volumes improve, pricing catches up and cost actions take hold.
Short-Cycle Momentum Not Fully in the Numbers Yet
The company pointed to improving short‑cycle activity and stabilization in the U.S., offering some early signs of demand recovery. However, management acknowledged that this momentum has not yet translated into strong organic growth at the enterprise level, and noted that year‑over‑year comparisons will become tougher as 2026 progresses.
Guidance Reaffirmed, Back-Half Weighted Execution
Ingersoll Rand reaffirmed its 2026 outlook, calling for total revenue growth of 2.5% to 4.5% with about 1% organic growth at the midpoint and roughly 2% from M&A. Adjusted EBITDA is projected at $2.13 billion to $2.19 billion and adjusted EPS at $3.45 to $3.57, implying about 5% growth at the midpoint, with first‑half EBITDA at roughly 45.5% to 46% of the full year and no net tariff or inflation hit anticipated to the guide.
The earnings call painted a picture of a company balancing strong cash generation, solid segment outperformance and active dealmaking against temporary but real operational and margin pressures. For investors, the key watchpoints will be ITS margin stabilization, the pace of order recovery and the conversion of a robust M&A and Life Sciences pipeline into sustained, higher‑quality growth.